Faeth Therapeutics is pioneering multi-node inhibition of the PAM (PI3K/AKT/mTOR) pathway, focusing on developing novel therapeutics to treat some of the most devastating types of cancer
Faeth Therapeutics is pioneering multi-node inhibition of the PAM (PI3K/AKT/mTOR) pathway, focusing on developing novel therapeutics to treat some of the most devastating types of cancer. Their lead candidate, PIKTOR, is designed to achieve deeper pathway suppression with greater tolerability by targeting multiple nodes simultaneously.